
Life sciences venture investor partnering with entrepreneurs to build healthcare companies across North America

A venture capital firm backing early-stage life science companies from Kirkland, Washington

Altitude Life Science Ventures looks for opportunities in early-stage life science companies operating in markets with significant demand and growth potential. Based in Kirkland, Washington, the firm backs teams it judges capable of building defensible, long-term businesses. Its scope goes beyond prescription drugs to cover any commercial application of technology that stems from advances in biology or chemistry, including AI and machine learning therapeutics, aesthetic and medical dermatology, and industrial or chemical reactions. The firm says its approach draws on experience in intellectual property strategic planning, which it uses to complement the work of its syndicate partners while carrying out extended due diligence before an investment decision. It describes this planning as integrating a company's core activities with the development and presentation of its patent portfolio worldwide, so that protection tracks the technology as it matures and moves through financing rounds.
Profile written by TrustList from the business's own published information, Sep 2026.
As of 2026-10-29. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Altitude Life Science Ventures.
Similar listings buyers compare against this one.

Life sciences venture investor partnering with entrepreneurs to build healthcare companies across North America

Indiana venture investor backing high-growth entrepreneurs in food, manufacturing, life sciences and technology

A venture capital firm backing artificial intelligence companies across many industries

Technology transfer company of the Hebrew University of Jerusalem working with industry and investors

Independent European venture capital firm investing in early-stage companies developing new therapeutics

Early-stage venture firm investing in seed-stage software and IT companies and staying on for follow-on rounds
Everything here links back to the same verified catalogue. Pick your next stop.